WAX-16474-06305
4 vaccinations
2 coded responses
32 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 895 / NV
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Registered in v-safe
-
2021-03-24
Dose 1 — Pfizer-BioNTech
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-30
- 2021-03-31
- 2021-04-09
-
2021-04-14
Dose 2 — Pfizer-BioNTech
- 2021-04-14
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-17
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-07-14
- 2021-10-13
-
2021-11-04
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-04-14
Survey response — 12 months, dose 2MedDRA: COVID-19, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend schoolFree text: I had COVID, tested positive on 1/31/22MedDRA releases: 2024-11 · check-in free text available
-
2022-10-17
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-19
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-20
- 2022-10-21
- 2022-10-22
- 2022-10-26
- 2022-10-31
- 2022-11-07
- 2023-01-16
-
2023-04-17
Survey response — 6 months, dose 4MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-17
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-04-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech | |
| 3 | 2021-11-04 | Pfizer-BioNTech | Flu |
| 4 | 2022-10-17 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-04-17 | Unsuccessful |
Free text
Release 11 — 12 months, dose 2
Symptoms: I had COVID, tested positive on 1/31/22
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release